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Abstract 
 
The leaves of Melia azedarach.L, family Meliaceae was tested for hepatoprotective activity 
against CCl4 in rats. The ethanol extract of Melia azedarach.L has shown significant activity, lowering the serum 
enzymes like SGOT and SGPT in rats intoxicated with CCl4. 
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Introduction 
 
Melia azedarach.L, family Meliaceae is from west Asia. It is widly distributed in Himalayan region between the 
attitude of 700 to 1000m. A moderate-sized deciduous tree 9-12m in height with a cylindrical bole with dark grey 
bark having shallow longitudinal furrows; The leaves are bi- or tripinnate, pinnate opposite or alternate, ovate or 
lanceolate, serrate, acuminate, glabrous on both surface, slightly oblique at the base.
1 It has been used for various 
medicinal purposes.
2 The leaf juice is used as an anthelmintic. It is also used to cure strangury, amenorrhoea, 
bronchitis, leprosy, eczema, asthma and as an antipyretic.
3 Phytochemical studies reveal the presence of 
alkaloids, flavanoids, steroids, tannins and lycopena etc.,
4 The present study was made to evaluate the effect of 
ethanol extract of Melia azedarach.L against CCl4-induced hepatic damage in rats. 
Melia azedarach.L against CCl4-induced hepatic damage in rats. 
Materials and methods 
The leaves of Melia azedarach. L were collected from the Western Ghats of Anamalai Hills, Coimbatore district, 
Tamilnadu. The plant was identified and authenticated by Botanical Survey of India (IBSI), Coimbatore, 
Tamilnadu, India. The leaves of the plant were collected and dried. The dried and powdered aerial parts of the 
plant (250gm) were extracted with ethyl acetate using soxhlet apparatus and concentrated in-vacuo. 
Approximately, 0.50g of dried ethanol extract was obtained from 30g of dried stem material. The extract was 
suspended in 50% gum acacia and used for studying hepatoprotective activity. 
 
Male albino rats weighing between 160 and 200 g were used as animal models. The rats were divided into four 
groups, each group consisting of six animals. Hepatoprotective activity of Melia azedarach.L, was evaluated 
using CCl4-induced model.
5 Group one was kept on normal diet and served as control, the second group received 
CCl4 (1.25 ml/kg) by oral route, the third and fourth group received silymarin (100 mg/kg; po) and extract of 
Melia azedarach. L (300 mg/kg; po) respectively once daily, for seven days. On the seventh day, CCl4 was given 
by oral route 30 min after the administration of silymarin and test drug. After 36h of CCl4 administration, blood 
was collected and serum separated was analyzed for various biochemical parameters. 
Biochemical parameters like serum glutamic oxaloacetic transaminase (SGOT) and serum glutamic pyruvate 
transaminase (SGPT) were determined by Reitman and Frankel method.
6 Serum alkaline phosphatase was 
determined by King and Kings method.
7 Malby and Evelyn method
8 was followed to estimate total bilirubin 
content. 
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using the standard microtecnique.
9 A section of the liver (5μm) stained with alumhemotoxylin and eosin was 
observed microscopically for histological studies. 
Results and discussion 
The results of biochemical parameters has shown the elevation of enzyme level in CCl4-treated group, indicating 
that CCl4 induces damage to the liver (Table 1). Liver tissue rich in both transaminase increased in patients with 
acule hepatic diseases, SGPT which is slightly elevated by cardiac necrosis is a more specific indicator of liver 
disease.
10 A significant reduction (P < 0.01) was observed in SGPT, SGOT, ALP and total bilirubin levels in the 
groups treated with silymarin and ethanol extract of Melia azedarach. L. The enzyme levels were almost restored 
to the normal. 
It is observed that the size of the liver was enlarged in CCl4-intoxicated rats but it was found to be normal in 
drug– treated groups. A significant reduction (P < 0.001) in liver weight supports this finding. 
It was found that the extract decreased the CCl4-induced elevated levels of the enzymes in group third and fourth, 
indicating the production of structural integrity of hepatocytic cell membrane or regeneration of damaged liver 
cells by the extract. 
Histopathological examination of the liver section of the rats treated with toxicant showed intense centrilobular 
necrosis and vaculization. The rats treated with silymarin and extracts along with toxicants showed sign to 
considerable extent as evident from formation of normal hepatic cards and absence of necrosis and vacuoles. 
Decrease in serum bilirubin after treatment with the extract in liver damage indicated the effectiveness of the 
extant in liver damage indicated the effectiveness of the extract in normal functional status of the liver. The 
phytochemical studies revealed the presence of flavonoids in ethanol extract of Melia azedarach. L various 
flavonoids have been reported for their hepatoprotective activity.
11 The hepatoprotective effect of Melia 
azedarach. L may be due to its flavonoid content. 
 
Table 1. Effect of ethyl acetate extract of Melia azedarach. L on CCl4 treated rats Design of treatment Liver (wt/100g) 
Design of  Liver(wt/100g  Dose(mg/kg)  SGPT  SGOT  ALP  Total  Bil 
treatment   body  wt    U/L  U/L  U/L   
Control   3.9±0.02  -----  131.7±2.03  44.8±0.77  166.4±3.11  0.79±0.02 
CCL4   6.2±0.29 1.25ml/kg  222.6±4.6  347.3±2.6  387.9±16.13  2.16±0.01 
Silymarin+CCl4 3.7±0.21  100  132.2±1.12  83.7±9.14  212.8±5.21  0.8±0.07 
Ethanol   4.6±0.17  300  117.4±1.09  68.5±5.21  287.9±4.96  0.84±0.01 
extract+CCL4              
 
N = 6 animals in each group. 
 
*P < 0.001; **P < 0.01 when compared 
with control. Values are expressed as 
mean + SE. 
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